Cargando…

32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study

Detalles Bibliográficos
Autores principales: Rankin, Brian D., Georgakopoulos, Jorge-Ryan, Sachdeva, Muskaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Mosby, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465237/
http://dx.doi.org/10.1016/j.jaad.2022.06.042
_version_ 1784787751499988992
author Rankin, Brian D.
Georgakopoulos, Jorge-Ryan
Sachdeva, Muskaan
author_facet Rankin, Brian D.
Georgakopoulos, Jorge-Ryan
Sachdeva, Muskaan
author_sort Rankin, Brian D.
collection PubMed
description
format Online
Article
Text
id pubmed-9465237
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Mosby, Inc.
record_format MEDLINE/PubMed
spelling pubmed-94652372022-09-12 32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study Rankin, Brian D. Georgakopoulos, Jorge-Ryan Sachdeva, Muskaan J Am Acad Dermatol Honorable Mention Published by Mosby, Inc. 2022-09 2022-09-12 /pmc/articles/PMC9465237/ http://dx.doi.org/10.1016/j.jaad.2022.06.042 Text en Copyright © 2022 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Honorable Mention
Rankin, Brian D.
Georgakopoulos, Jorge-Ryan
Sachdeva, Muskaan
32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study
title 32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study
title_full 32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study
title_fullStr 32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study
title_full_unstemmed 32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study
title_short 32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study
title_sort 32414 incidence and prognosis of covid-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study
topic Honorable Mention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465237/
http://dx.doi.org/10.1016/j.jaad.2022.06.042
work_keys_str_mv AT rankinbriand 32414incidenceandprognosisofcovid19inpatientswithatopicdiseasesondupilumabamulticentreretrospectivecohortstudy
AT georgakopoulosjorgeryan 32414incidenceandprognosisofcovid19inpatientswithatopicdiseasesondupilumabamulticentreretrospectivecohortstudy
AT sachdevamuskaan 32414incidenceandprognosisofcovid19inpatientswithatopicdiseasesondupilumabamulticentreretrospectivecohortstudy